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Background: In Barbados sexually transmitted infections (STIs) including HIV are not notifiable diseases and there
is not a formal partner notification (PN) programme. Objectives were to understand likely attitudes, barriers, and
challenges to introducing mandatory disease notification (DN) and partner notification (PN) for HIV and other STIs
in a small island state.
Methods: Six key informants identified study participants. Interviews were conducted, recorded, transcribed and
analysed for content using standard methods.
Results: Participants (16 males, 13 females, median age 59 years) included physicians, nurses, and representatives
from governmental, youth, HIV, men’s, women’s, church, and private sector organisations.
The median estimated acceptability by society of HIV/STI DN on a scale of 1 (unacceptable) to 5 (completely
acceptable) was 3. Challenges included; maintaining confidentiality in a small island; public perception that
confidentiality was poorly maintained; fear and stigma; testing might be deterred; reporting may not occur;
enacting legislation would be difficult; and opposition by some opinion leaders.
For PN, contract referral was the most acceptable method and provider referral the least. Contract referral unlike
provider referral was not “a total suspension of rights” while taking into account that “people need a little gentle
pressure sometimes”. Extra counselling would be needed to elicit contacts or to get patients to notify partners.
Shame, stigma and discrimination in a small society may make PN unacceptable and deter testing. With patient
referral procrastination may occur, and partners may react violently and not come in for care. With provider
referral patients may have concerns about confidentiality including neighbours becoming suspicious if a home
visit is used as the contact method. Successful contact tracing required time and effort. With contract referral
people may neither inform contacts nor say that they did not.
Strategies to overcome barriers to DN and PN included public education, enacting appropriate legislation to
allow DN and PN, good patient counselling and maintaining confidentiality.
Conclusions: There was both concern that mandatory DN and PN would deter testing and recognition of the
benefits. Public and practitioner education and enabling legislation would be necessary, and the public needed
to be convinced that confidentiality would be maintained.
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Disease notification (DN) is the reporting by a physician,
other health care provider or laboratory of the occurrence
of specified notifiable diseases to a designated public health
agency [1]. Reporting is regulated by public health legisla-
tion. For sexually transmitted infections (STIs), partner
notification (PN) is the process by which sex partners of in-
fected persons are informed of their exposure to infection
and offered testing, prevention counselling and treatment
[2,3]. In the case of blood borne STIs, this would extend to
needle sharing partners.
DN along with PN can ensure the proper follow up
and management of individual cases by public health au-
thorities and interrupt the chain of STI transmission
[3,4]. On the population level DN by itself can be used
for disease surveillance, allowing the monitoring of dis-
ease trends and thereby providing information necessary
for the development of public health policy, resource
allocation, and the assessment of the effectiveness of
prevention and care programmes [4]. The Centers for
Disease Control and Prevention (CDC) recommends
that HIV/AIDS DN should be complete (recording ≥
85% of cases), timely (≥66% of cases reported within
6 months) and accurate (≤5% duplicate case reports). A
confidential name-based system is most likely to meet
these criteria and fulfil the public health purposes for
which the surveillance data are required [5]. However
there has been concern that name-based HIV reporting
might discourage people from getting tested because of
fear that their names “might fall into the wrong hands”
[6] and the CDC strongly promotes the concurrent
availability of anonymous testing options [5]. Data from
six states in the USA with a low HIV prevalence [7],
New York State with a higher prevalence [8] and from
Alberta, Canada another low prevalence area [9] suggest
that the introduction of confidential name-based DN
will not have a significant impact on testing rates. In the
UK, voluntary HIV DN using a combination of soundex
codes based on the surname and date of birth has
proven efficient in identifying duplicates. The use of ini-
tials, date of birth, and gender together may also be effi-
cient in excluding duplicates [10].
Notifiable disease reporting completeness is highly
variable and is related to the disease, physician and
patient concerns about confidentiality, physician know-
ledge of reporting procedures, administrative difficulties,
and whether a passive or active surveillance system is in
place [11-13].
Three main approaches to PN are recognized: patient
referral, provider referral, and contract referral. Patient
referral gives the index case the responsibility of contact-
ing partners and asking them to present for treatment.
Provider referral gives health care personnel the respon-
sibility of obtaining the names and contact informationof the partners of the index case and then contacting
them. DN can facilitate this process. With contract refer-
ral the index case is encouraged to notify their partners,
with the understanding that health service personnel will
notify those partners who do not visit the health service
by an agreed date [2,3]. PN identifies a high-prevalence
population and should be part of any STI prevention
and treatment programme [2,14,15]. A review of HIV
partner counselling and referral services in high-income
countries estimated that with provider referral 67% of
named partners were notified, 63% of those notified
were tested and 20% of tested individuals were newly di-
agnosed with HIV [2]. Provider referral or the choice
between provider referral and patient referral, compared
with patient referral for patients with any STI may
increase the rate of partners presenting for medical
evaluation [16,17]. However, a recent systematic review
did not identify a single optimal strategy of PN for any
particular STI as there were too few trials to allow con-
sistent conclusions about the relative effects of provider,
contract or other patient referral methods for different
STIs [3]. For curable STIs both patients and doctors
may prefer patient referral [18,19]. Provider referral is
more costly than patient referral and may not be suc-
cessful if it is perceived to threaten patient confidential-
ity [20]. The significant benefit of HIV treatment is a
strong reason for encouraging individuals exposed to
HIV to be tested [2]. Notified contacts may however suf-
fer harms such as stress, emotional trauma, domestic
violence, partnership dissolution, a loss of confidential-
ity, stigmatization and discrimination [2]. In a survey of
HIV infected persons in Barbados 71% reported that
they had self-disclosed their status to their steady part-
ner, but only 26% to casual partners. Reasons given for
nondisclosure included fear of stigma, discrimination,
loss of confidentiality and rejection [21].
Barbados is an island of only 430 Km2. It has a popula-
tion of 277,821 [22]. The estimated prevalence of Chla-
mydia is 11.3% and gonorrhoea 1.8% in people 18 to
35 years of age [23]. For HIV the estimated prevalence
among 15 to 49 year olds is 1.2%. Between 1984 when
the first HIV case was diagnosed and 2011 there have
been 3559 people diagnosed with HIV, 2375 AIDS cases
and 1643 deaths [24]. Voluntary counselling and confi-
dential HIV testing using a code rather than name to
identify specimens sent to the laboratory is available free
through publicly funded polyclinics, and for a fee through
private practitioners. Anonymous testing is not done [25].
Point-of-care HIV testing is not usually done, and col-
lected blood is tested at a single public laboratory. Other
STI laboratory testing is done at both public and private
laboratories with specimens identified with the patient’s
name. Since 2002 free antiretroviral treatment has been
available to all HIV infected people through a centralised
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able diseases in Barbados and there is no formal PN
programme. There is limited published information on
the attitudes and challenges to DN and PN in Barbados
and other small island states, and these may be different
from what is seen in larger countries. By understanding
the likely attitudes of people in Barbados to DN and PN,
public health policy can be developed that is culturally ap-
propriate and more likely to be accepted. The objectives of
this study were to interview a diverse group of people in
Barbados in order to understand the likely attitudes, bar-
riers, and challenges to introducing mandatory DN and
PN for HIV and other STIs in a small island state.
Methods
This was a focused ethnographic study conducted in
2005. This type of research not only describes behaviour
but also tries to understand why people do what they
do. A survey or quantitative approach would not gener-
ate the rich information that qualitative interviews could.
The reporting of this study adheres to the RATS guide-
lines for qualitative studies [27].
Sampling
Study participants from diverse backgrounds were inter-
viewed. They ranged from health care workers directly
involved in STI/HIV/AIDS work in Barbados to non-
health care workers not directly involved in such work
(Table 1). An attempt was made to ensure that study
participants represented important sub-populations. Par-
ticipants had to be resident in Barbados and be ≥16 years
of age. An equal distribution between the two genders
was a priority. Based on the saturation model, the aim
was to conduct interviews until no new data emerged.
Study participants were selected by interviewing six key
informants. Key informants were individuals identified as
having good community contacts and knowledge. They
were chosen through snowball sample technique on the
recommendation of knowledgeable community members.
The sampling method in both the key informant and the
individual interviews were purposive. Individuals wereTable 1 Description of study participants by category and ge
Category Description
Health care workers (HCW) 5 physicians, 2 nurses inv
Government position (Govt) 1 physician, 1 social work
non-medical organisation
People living with HIV/AIDS (PLWHA) 3 people from organisatio
Nongovernmental organisations (NGO) Representatives of youth
groups, 2 churches, 2 priv
non-governmental organiselected based on their level of cultural knowledge of the
topic.
Data collection
A fieldworker was hired and trained to do the recruitment
and interviews. The study participants were asked to read
an information sheet, sign a consent form and fill out a
personal demographic information sheet. Consent in-
cluded permission to have the interviews tape-recorded
and transcribed. Participant interviews were conducted in-
dividually using an open-ended semi-structured interview
guide (Additional file 1). Transcriptions were labelled with
a code.
Understanding of DN was first determined, and if ne-
cessary an explanation of DN was given and understand-
ing checked again. The participant’s attitude towards DN
for STI including HIV, opinion on the acceptability to
society of DN for these conditions, rating of the accept-
ability to society on a scale of 1 (unacceptable) to 5
(completely acceptable), identification of groups that
would support and oppose DN, and barriers and chal-
lenges to the implementation of DN were obtained.
After this a review of the statements made was done to
validate the researcher’s interpretation of data collected,
and finally further comments were invited. Participant
understanding of PN was then assessed, terms were de-
fined and understanding re-assessed if needed. The same
areas as for DN were explored for provider, patient and
contract referral in turn. Participants then ranked the ac-
ceptability of the 3 methods of PN with the help of show
cards, then a review of the statements made. Interviews
took approximately 60 to 90 minutes each.
Analysis and interpretation of the data
The 3 authors conducted independent analysis of tran-
scribed participant interviews. Participants were categorised
into demographic groups – health care workers (HCW),
government position (Govt), people living with HIV/AIDS
(PLWHA), and non-governmental organisations (NGO)
which included representatives of youth groups, men’s
groups, women’s groups, the private sector, and the churchnder
Number gender
olved in Public Health HIV care 4 male
3 female




ns concerned with HIV, 1 person with HIV 3 male
1 female
organizations, 2 men’s groups, 2 women’s
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tifying themes from the transcripts and developing their
own coding framework. The codes were then compared
and integrated into a common framework. All 29 tran-
scripts were then coded using the common framework, and
then amalgamated by category of participant and type of
PN. Information from each category of participant and type
of PN was analysed separately, then compared together so
that triangulation of data occurred, and then a summary
done. Quotes were chosen in order to illustrate a range of
views from different participants. Medians were calculated
for the estimated acceptability DN and the different forms
of PN.Ethical approval
Ethical approval was received from the Institutional Review
Board of the School of Clinical Medicine and Research
(now the Faculty of Medical Sciences), Cave Hill Campus,
University of West Indies.Results
Twenty-nine participants (16 males, 13 females) (Table 1),
with a median age of 59 years (range 30 to 68) were
interviewed.Current DN and PN practices
Few (HCW, Govt, PLWHA) were aware of current DN
and PN practices. HIV/STI DN was described as an
informal process rather than a legal requirement (HCW).
HIV testing was done at a single public laboratory. La-
boratory workers would not know the name of the pa-
tient as specimens were labelled with a code. When a
positive test was obtained, the laboratory director con-
tacted the doctor who requested the test, to obtain in-
formation on the patient (HCW, Govt). For HIV “the
present system of DN is actually quite good” (HCW),
while another person felt that it was not practical
(PLWHA). For other STIs public sector polyclinics but
not private physicians reported the number of cases di-
agnosed each week to the Ministry of Health (HCW).
Health care workers said that there was no legislation
specifically governing PN, and current practices incor-
porated elements of patient, provider and contract re-
ferral. Patients were encouraged to reveal their status
to partners and encourage them to come in for testing.
One person said that if this failed they would ask for
the partner’s name and inform the partner without re-
vealing the name of the infected person. Another per-
son said that a doctor or the public health nurse
contacted partners and told them what infection they
are exposed to.Acceptability
Society’s acceptance of DN The estimated acceptability
by society of HIV/STI DN had a median score of 3 on a
scale of 1 (unacceptable) to 5 (completely acceptable).
Making STIs notifiable diseases would be controversial
as it dealt with a very personal and sensitive issue in a
society that does not openly discuss such matters and
tends to stigmatise persons with STIs (Govt). The differ-
ence between success and failure might depend on way
it was “marketed” and the extent of an anticipated public
“outcry” that would occur with its introduction (HCW).
Some felt that DN might not be accepted because of a
lack of trust and concerns about confidentiality. Accept-
ability would improve once it became clear that confi-
dentiality would be respected (Govt). Others felt that
society would accept HIV DN since there had not been
a negative reaction to the current informal system, and
people realised that HIV was an important problem
(HCW, Govt).
Some (PLWHA) estimated that 50 to 75% would sup-
port DN but they would want it for everyone else except
themselves. “I think that there are people who would
support it because they are of the perception that it will
never apply to them, you know that” (NGO).
Study participants’ acceptance of DN Most partici-
pants were in support of HIV DN. HIV is a public health
concern and DN would allow for appropriate policy to
be developed to help manage it (Govt, NGO). The col-
lection of names and addresses was necessary for accur-
ate data as persons had the tendency of being retested
when first diagnosed (Govt). It needed to be in place if
the spread of HIV was to be slowed (NGO). Comments
included that it was “an important tool”, “long overdue”
(HCW), “Barbados really needs it right now”, “I think it
would work” (NGO), “a good idea because you have an
opportunity to better track the disease” and “the church
would certainly stand behind this” (NGO). Although
people had “rights” there are always exceptions such as
the public interest (Govt).
A few were not in support of DN for HIV. One person
said that it was already known that HIV was an epidemic,
and could not see how DN would help anything (Govt)
and another said that information between a patient and a
doctor should remain confidential (PLWHA).
Acceptability of PN
For HIV most felt that contract referral would be the
most acceptable method of PN and provider referral the
least acceptable method to society. When acceptability
of each method of PN was rated on a scale of 1 (un-
acceptable) to 5 (completely acceptable) the median
score was 4 for both contract and patient referral, and 3
for provider referral. Contract referral allowed shared
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given the first chance to inform the partner. Unlike pro-
vider referral it was not “a total suspension of rights”
while taking into account that “people need a little gentle
pressure sometimes” (HCW).
The acceptability of provider referral would be slightly
better with STIs other than HIV. “People don’t like to
hear the news (about STI) but they don’t pull people out
of the house” (HCW).Barriers and challenges to disease and partner notification
Confidentiality For both DN and PN many noted that
maintaining confidentiality would be especially challen-
ging in a small island like Barbados where many people
know each other. “What I am wondering is how much
confidentiality will be there considering that Barbados is
so small and everybody know everybody”. “It is so hard
to keep things private in Barbados (NGO). In addition
Barbadians were said to have an excessive interest in the
business of others while being very secretive about their
own health, resulting in a particularly difficult environ-
ment for implementing DN. “Sociologically Barbadians
are still very concerned about divulging even basic diseases
like diabetes. Bajans (Barbadians) are very secretive, very
conservative” (NGO).
With DN and PN even an isolated breach of confiden-
tiality might cause a significant loss of trust in the sys-
tem. It may be sufficient to turn the system “upside
down” (NGO). It would be difficult to identify who was
responsible. In some cases it may be a spouse or friend.
Even if not at fault, health care workers would take most
of the blame.
There was some scepticism that the systems in place
could maintain confidentiality. With DN access to the
information might not be adequately restricted. People
are afraid that the information “will be put in a file in a
government department where somebody could be the of-
ficer this year, then next year it is somebody else, or next
month somebody goes on vacation and someone comes in
and sees confidential information. People are afraid of
that” (NGO). Many were of the view that confidentiality
was not well maintained in Barbados and the public
therefore lacked trust in the system. Not all professionals
respected confidentiality. “People in private sector (banks)
breach confidentiality, so why is this different?” “A lot of
people will not believe that it is confidential. Nobody in
Barbados trusts anyone else” (NGO). “I don’t think that of-
ficialdom is aware of what people feel. They just feel that
there is no confidentiality in the system because they have
had bad experiences.” “Because of our small society they
are afraid that other persons would know, afraid that con-
fidentiality would be breached” (NGO). With PN a partner
once informed may become angry and tell someone.Judgmental attitudes of health care workers and a lack
of trust in them may also be barriers.
“Apart from being a very gossipy society we’re also a
very judgemental society especially when it comes to
morals and ethics and as you know sex and sexuality
...... which we don’t talk a lot about.... we judge people
by their sexual practices a lot” (Govt).
Stigma and discrimination made concerns about confi-
dentiality even more important. “..some people who are
run out of their work places not because their employers
say I can’t employ you but people are treated differently. ....
I mean a man only must begin to lose weight and the first
thing people (are going to) ask him ‘you got AIDS’, ‘you see
so and so, he losing very much weight yuh!.’ (NGO).
Effect on HIV testing People will not want to be tested
because of concerns about confidentiality, and stigma,
discrimination and embarrassment associated with infec-
tion (HCW, NGO).
“It (DN) may appear to have short-term advantages…
but people are not going to then come forward for any
voluntary testing”. “There are some who would want
to fly out of Barbados to get medical attention”
(NGO).
Mandatory PN may deter people from returning for
their results. Some may resort to home HIV tests. People
may delay accessing care and present late with “full
blown” AIDS.
Historical concerns Historical approaches to STI care
provide negative examples. Confidentiality was lacking
as there were identifiable STI clinics, and health care
workers doing PN were easily identified.
Opposition Politicians, prominent persons with a reputa-
tion to protect and other opinion leaders might oppose
DN and PN. Despite the view that health care profes-
sionals would support legislation mandating DN one
person felt that those working in STI clinics “know that a
blanket notification really inhibits people rather than
helps” (HCW). Persons engaged in high risk activities, and
people living with HIV might also oppose mandatory DN.
The church may be divided on the issue.
Legislation There may be a lack of political will to enact
legislation to enable DN. Health care workers would have
to convince the politicians that that this is important.
Some may feel it infringes human rights and there may be
an orchestrated campaign against it via call in radio
programmes.
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diseases. DN has not worked in the case of other dis-
eases as doctors did not bother to report cases (HCW).
People may feel that if they went to private practitioners
the process may not apply (NGO).
Partner notification barriers and challenges
Extra counselling would be needed to get patients to notify
partners, or to give the provider permission to do so. Pre-
test counselling was however often inadequate as doctors
did not always have the skill or the time, and were often
reluctant to refer patients to other professionals. The pa-
tient may not want the partner notified because of denial,
fear and shame. There could be concern over partner
reaction e.g. domestic violence (physical and mental), and
a loss of economic support including being put out of the
house.
The patient may not know the name or contact details
of partners as “one night stands” were common and one
interviewee believed that less than 50% of partners would
be reached (NGO). This would also be true for sex
workers and people who had sex while travelling.Patient referral
With patient referral notification may not occur as some
people would simply not care, some may not accept the re-
sponsibility, procrastination would occur and people may
not notify partners despite promising to do so. It took cour-
age to notify a partner, and many may not have this cour-
age. “…I have a difficulty in seeing that type of courage”
(Govt). As a result persons might rationalise the situation.
“…like if you going to have it she already got it so why
worry”, and many persons keep quiet and only reveal it in
their dying days, or when they are so ill that it is noticeable
(NGO). Giving bad news especially if it is face-to-face and
revealing infidelity with multiple people to a close partner
would be difficult. Partner reaction especially violence
would be a concern.“… if you have people with a short fuse,
short tempers the person might grab the other person and
want to lash out at the other person”. “I’ve heard stories of
people being attacked for less” (NGO).
With patient referral less than half of notified partners
might come in for care (Govt). With provider referral they
will know that a mechanism is in place for treatment and
might be more inclined to get treatment (NGO).
Provider referral
Although rated the least acceptable method to the public
some might prefer provider referral. Not everyone would
want to contact his or her partners themselves and it
would reduce the possibility of violence and conflict asso-
ciated with patient referral. However several challenges
were identified.Time and effort was needed for successful contact tra-
cing, and without appropriate legislation difficulties
could arise unless the patient gave permission. People
would see it as a breach of trust. It is not “a simple thing
of saying all right you have been diagnosed that’s your
wife let me go and tell her” (HCW). Contacts may not
welcome unknown health care workers knowing their
sexual history and how to contact them.
Maintaining confidentiality would be a greater challenge
compared to patient referral as contact tracing requires
additional persons having access to the results. “There are
a lot of people involved, a great risk of confidentiality lost,
and you have no guarantee at the end of the day, that the
person is going to give you the correct list anyway” (HCW).
Given the small size of Barbados, people would be con-
cerned that someone in the public health department with
access to the information would know them (Govt). It
would only be possible to keep the infected person’s iden-
tity secret if the contact had multiple partners. Additionally
the contact tracer might reveal the name of the infected
person, or might be pressured into doing so by a contact
demanding to know who put them at risk. There may be
hostility towards the contact tracer, especially if the name
of the index case is not revealed. Family and neighbours
may become suspicious if a health care provider associated
with provider referral visits a home. Notification had to be
done discretely without neighbours being able to guess
what is happening, but people would be concerned that
over time in a small place like Barbados the word would
get out. With tuberculosis, a notifiable disease, people did
not like it when the public health nurse visited the home,
so the same may be true for STI, particularly HIV.
The patient may not reveal the names of partners be-
cause of concerns about confidentiality, stigmatisation,
judgmental attitudes of health care workers and violence;
or they may simply not know the names. One or two per-
sons may be left off the list of contacts, especially if there
is something threatening about those partners. There
would be no way to force a person to disclose the name of
their partners. Alternatively an angry patient might give
names of persons who were not contacts. Even if the name
was obtained the contact may not come in to be tested.
Contract referral
With contract referral a health care worker doing the
notification may be seen as breaking confidentiality. A
patient may have “valid reasons” for not notifying a part-
ner and it may be seen as “prying into people’s personal
affairs” (NGO). One person felt that it was best to tell
patients that either patient or provider would inform the
contact.
Determining the correct length of time to allow the
patient to notify partners could be a challenge. Some
persons will feel that they were not given enough time,
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to locate, but too much time could result in a delay in
the partners being informed, and during that period they
could become infected. People had a tendency not to
honour verbal contracts, and could always deny that a
contract was made. Many would neither inform their
partners nor get back to the health care worker to say
that they did not.
Strategies to make disease and partner notification work
Trust has to be created and fear reduced before DN or
provider referral legislation is introduced. It was felt that
a carefully planned public education campaign letting
people know there were plans to introduce DN and PN,
stressing the importance and reassuring the public that
confidentiality would be maintained and attitudes would
be non-judgmental was necessary. The required public
education would take a long time. “They would have to
be absolutely certain that it would go as written, that is
nobody would be snickering or pointing fingers at them”
(NGO). People would accept it only if confident that
confidentiality was assured (NGO, Govt). For the infor-
mation campaign to be effective the public had to be
‘bombarded with information’ over a prolonged period
(HCW). “A little jingle on the radio wouldn’t do it”
(NGO). Public education messages however do not
reach all people (PLWHA), and specific groups would
have to be targeted (NGO). In addition to using the
mass media, education should be taken to the schools
and workplace (NGO). Education should be done at the
community level, with a focus on young people and the
lower income groups (NGO).
“It would have to be clearly explained, let people
understand that these numbers are necessary and only
the smallest possible circle of persons will have this
information. In other words it will not be a case where
any clerical officer or any person in any government
department will be able to pull out a file and see a
person’s information” (NGO).
Maintaining confidentiality In order to maintain confi-
dentiality education of staff was also needed. There had
to be repeated training of staff dealing with the informa-
tion and just not a one off effort (Govt). The conse-
quences of breaching confidentiality such as the public
losing trust in the system had to be made clear (NGO).
Penalties would be needed to sanction those who breach
confidentiality. With provider referral one had to be
careful that the provider visiting a home is not known
by the community to be associated with STI contact tra-
cing. Alternative methods would have to be considered.
“I would imagine that people would have to be contacted
by telephone, more so because you can’t have peopletraipsing up to people’s houses in vehicles that people
identify to be government vehicles or persons” (NGO).
Legislation Legislation sanctioning DN and provider re-
ferral would have to be enacted.
Discussion
Study participants were generally in favour of mandatory
DN however they felt that the public would be less
accepting. They felt that both contract and patient refer-
ral would be acceptable forms of PN in Barbados, but
had concerns about the effectiveness of patient referral.
Stigma and discrimination were significant concerns
from a societal perspective, and for any method to be ac-
ceptable maintaining confidentiality would be important.
Effect of mandatory DN on HIV testing
While the benefits of HIV DN and PN were appreciated by
study participants there was fear that less people would
come forward for testing or test results or may not provide
the names of contacts largely due to concerns about confi-
dentiality and the stigma associated with infection. Re-
search indicates that people may provide more names for
provider referral if they believe confidentiality is assured
[20]. However, several studies from other countries suggest
that DN regulations are a minor factor in HIV testing deci-
sions with testing rates remaining the same after mandatory
name-based DN was introduced [7-9], even if prior to the
implementation there was a fear that rates would decrease
[9]. Fear of receiving a positive test result and the assump-
tion of being uninfected remain major reasons for not
being tested [6]. However the situation could differ in
Barbados because its small size makes confidentiality chal-
lenging to maintain, people are secretive about their health,
and there is the perception confidentiality has been
breached in the past. Confidentiality is particularly im-
portant in small societies with conditions that generate
much stigma and fear. If confidentiality is breached or
if patients believe that it may be breached they may not
come forward for testing and both the individual and
the public may suffer [28]. As encouraging people to
become aware of their HIV/STI status is a major public
health objective the introduction of an anonymous test-
ing option should be considered.
Maintaining confidentiality
Participants suggested that there should be repeated
training of staff in maintaining confidentiality, the conse-
quences of even an isolated breach in confidentiality to
public trust should be made clear and penalties should
be introduced for those breaking confidentiality. In
addition there was concern that unsecured DN informa-
tion might be accessed by persons visiting the office
where the records were kept. The CDC suggests that
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cured area and be password and computer encryption
protected, and access should be restricted to a minimum
number of surveillance staff. In addition when surveil-
lance data is made available for epidemiologic analyses
names should be removed [5]. Adoption of these mea-
sures should help in maintaining trust. With DN the
acceptability of using soundex codes and date of birth
rather than actual names were not specifically explored
by this study. While acceptable in larger countries [10]
there may be concerns in a small island.
With provider referral it was also felt that over time
in a small island contact tracers visiting homes would
become known to the community and neighbours ob-
serving them would become suspicious. In a UK survey
respondents felt that a mobile telephone text message,
private email and private letters requesting the person
to attend a clinic, rather than a message informing
them that they have a STI would be good methods of
PN [18].Completeness of DN
DN will provide accurate data only if reporting is
complete. Legislation regulating DN would ensure that
health care workers are protected when they reveal the
requested information, and would provide a mechanism
for the information be forwarded on the physician’s ini-
tiative. It would allow for the results of point-of care
tests, which are likely to become more prevalent in the
future, to be captured. Similarly legislation would be
needed to facilitate provider and contract referral. Main-
tenance of trust requires patients to be informed of the
reporting system before being tested.
In the USA reasons cited for health-care providers and
laboratories not reporting notifiable diseases include a lack
of knowledge of which diseases are reportable, the legal re-
quirement to report these diseases and how to report; an
assumption that someone else will report the case;
intentional failure to report to protect patient privacy; and
insufficient reward for reporting or penalty for not report-
ing. Interventions aimed at reducing these barriers have
had limited success [29]. It is essential that an active HIV
surveillance system in Barbados be maintained with the
physician being contacted when a positive test is obtained
by the laboratory. Inactivity by health departments can be
a contributing factor to under-reporting [11].Partner notification acceptability and effectiveness
Contract referral and provider referral were chosen as the
most and least acceptable methods respectively to the
public. Contract referral was seen as preserving patient
autonomy to some extent, while still allowing the provider
to act if the patient did not thus increasing effectiveness.Other surveys have found that for STIs people may indi-
cate that patient referral would be preferred over provider
referral if they were to test positive [18], but the method
preferred may vary by type of partner (close or casual)
[20]. In Barbados, infected people are more likely to report
that they had informed a regular (versus a casual partner)
of their status, and some continued to have unprotected
sex without doing so [21].
Patient referral may be less effective than provider or
contract referral [16,17]. In a randomised controlled trial
in North Carolina, USA 50% of partners of HIV infected
people were notified in the provider referral arm but
only 7% by patient referral despite a law requiring part-
ners to be notified [16]. In our study, participants sug-
gested several reasons why infected people may have
difficulty with patient referral. In addition to concerns
about violence, loss of economic support, shame in hav-
ing to admit unfaithfulness to a regular partner and a
loss of confidentiality, not being able to locate partners
easily, a lack of concern, not liking to give bad news and
procrastination were mentioned. Patients should be
trained to instruct sex partners sensitively about their
potential risk of infection [30] and this may be helpful in
overcoming some of these barriers. Dual referral where
both the patient and provider jointly notify the partner
of exposure [31] may be another strategy to use. How-
ever some emotional distress and anger are to be ex-
pected if a partner believes that he or she has been
unknowingly exposed to HIV [2].
Limitations
A survey of the public, including people receiving a STI
diagnosis would be needed in addition to this study to
more completely explore attitudes to DN and PN.
Conclusions
There was both a concern that mandatory DN and PN
would adversely affect testing and a recognition of the
benefits of their introduction. The introduction of DN
and PN would require appropriate legislation and would
have to be preceded by a sustained education and aware-
ness campaign explaining the importance of DN and PN
and how the system will maintain confidentiality. The
latter would include measures to physically secure sur-
veillance data, repeated staff training, penalties for
breaching confidentiality and in the case of provider re-
ferral a discrete contact method. Extra resources would
be needed for counselling and the contact tracing re-
quired with provider referral.Additional file
Additional file 1: Interview guide.
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